PlainRecalls
FDA Devices Moderate Class II Terminated

ST AIA-PACK Homocysteine (HCY) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of homocysteine in human serum, heparinized plasma or EDT A plasma on TOSOH AIA System Analyzers. Homocysteine measurements are used in the diagnosis and treatment of hyperhomocysteinemia or homocysteinuria.

Reported: January 2, 2019 Initiated: November 30, 2018 #Z-0675-2019

Product Description

ST AIA-PACK Homocysteine (HCY) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of homocysteine in human serum, heparinized plasma or EDT A plasma on TOSOH AIA System Analyzers. Homocysteine measurements are used in the diagnosis and treatment of hyperhomocysteinemia or homocysteinuria.

Details

Recalling Firm
Tosoh Bioscience Inc
Units Affected
992 units
Distribution
US Nationwide
Location
Grove City, OH

Frequently Asked Questions

What product was recalled?
ST AIA-PACK Homocysteine (HCY) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of homocysteine in human serum, heparinized plasma or EDT A plasma on TOSOH AIA System Analyzers. Homocysteine measurements are used in the diagnosis and treatment of hyperhomocysteinemia or homocysteinuria.. Recalled by Tosoh Bioscience Inc. Units affected: 992 units.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 2, 2019. Severity: Moderate. Recall number: Z-0675-2019.